When should we measure Vitamin D concentration in clinical practice?

References

• Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, . Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–1930.
   PubMed Web of Science ®Google Scholar
• Ross C, Manson JE, Abrams S, Aloia J, Brannon P, Clinton S, . The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011;96:53–58.
   PubMed Web of Science ®Google Scholar
• Norman A. Vitamin D nutrition is at a crossroads. Public Health Nutrition 2011;14:750–751.
   Google Scholar
• Adams J, Hewison M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471–478.
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckardt P, Fuleihan GEH, . IOF position statements: vitamin D recommendations for older adults. Osteoporos Int 2010;21:1151–1154.
   PubMed Web of Science ®Google Scholar
• Perez-Lopez F, Brincat M, Erel T, Erel T, Tremollieres F, Gambacciani M, . EMAS position statement: vitamin D and postmenopausal health. Maturitas 2012;71:194–198.
   Google Scholar
• Vieth R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89: 575–579.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari H, Giovanucci E, Willett W, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple outcomes. Am J Clin Nutr 2006;84:18–28.
   PubMed Web of Science ®Google Scholar
• Dawson-Hughes B, Heaney R, Holick M, Lips P, Meunier P, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713–716.
   PubMed Web of Science ®Google Scholar
• Hanley D, Cranney A, Jones G, Whiting S, Leslie W, Cole D, . Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:E610–E618.
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Body JJ, Lappe J, Plebani M, Schoenfeld Y, Wang T, . Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmunity Reviews 2010; 9:709–715.
   PubMed Web of Science ®Google Scholar
• Mithal A, Wahl DA, Bonjour JP, Burckardt P, Dawson-Hughes B, Eisman J, . Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;11:1807–1820.
   Google Scholar
• Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008;3:1535–1541.
   PubMed Web of Science ®Google Scholar
• Cashman K, Fitzgerald A, Kiely M, Seamans K. A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br J Nutr 2011;106: 1617–1627.
   PubMed Web of Science ®Google Scholar
• Leu M, Giovannucci E. Vitamin D: epidemiology of cardiovascular risks and events. Best Practice & Research Clinical Endocrinology & Metabolism2011;25:633–646.
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 2011;29: 3775–3782.
   PubMed Web of Science ®Google Scholar
• Munger K, Levin L, Hollis B, Howard N, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832–2838.
   PubMed Web of Science ®Google Scholar
• Bodnar L, Catov J, Simhan H, Holick M, Powers R, Roberts J. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab 2007;92:3517–3522.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–81.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari H. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 2007;18: 401–407.
   Google Scholar
• Vieth R, Bischoff-Ferrari H, Boucher B, Dawson-Hughes B, Garland C, Heaney R, . The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649–650.
   PubMed Web of Science ®Google Scholar
• Heaney R, Davies M, Chen TC, Holick M, Barger-Lux J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204–210.
   PubMed Web of Science ®Google Scholar
• Yendt E, Kovacs K, Jones G. Secondary hyperparathyroidism in primary osteoporosis and osteopenia: optimizing calcium and vitamin D intakes to levels recommended by expert panels may not be sufficient for correction. Clinical Endocrinology 2008;69:855–863.
   Google Scholar
• Schlingmann KP, Kaufmann M, Weber S, Irwin A, Goos C, John U, . Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N Engl J Med 2011;365:410–421.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari H, Willett W, Wong J, Stuck A, Staehelin H, Orav J, . Prevention of nonvertebral fractures with oral vitamin D and dose dependency. Arch Int Med 2009;169: 551–561.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari H, Dawson-Hughes B, Staehelin HB, Orav J, Stuck A, Theiler R, . Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:b3692.
   PubMed Web of Science ®Google Scholar
• Priemel M, von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, . Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res 2010;25:305–312.
   PubMed Web of Science ®Google Scholar
• Okazaki R, Sugimoto T, Kaji H, Fujii Y, Shiraki M, Inoue D, . Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D3 supplementation load in Japanese patients. J Bone Miner Metab 2011;29:103–110.
   PubMed Web of Science ®Google Scholar
• Cavalier E, Rozet E, Gadisseur R, Carlisi A, Monge M, Chapelle JP, . Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut-offs. Osteoporos Int 2010;21:1047–1051.
   PubMed Web of Science ®Google Scholar
• Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M. Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int 2008;19:991–999.
   Google Scholar
• Davidson Z, Walker K, Truby H. Do glucocorticoids alter vitamin D status? A systematic review with meta-analyses of observational studies. J Clin Endocrinol Metab 2012;97 (in press).
   Google Scholar
• Camacho P, Dayal A, Diaz J, Nabhan F, Agarwal M, Norton J, . Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. J Clin Oncol 2008;26:5380–5385.
   Google Scholar
• KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009; 79:S1–S130.
   Google Scholar
• Kandula P, Dobre M, Schold JD, Schreiber M, Mehrotra R, Navaneethan S. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol 2011;6:50–62.
   PubMed Web of Science ®Google Scholar
• Jean G, Souberbielle JC, Chazot C. Strategy for vitamin D supplementation. Monthly cholecalciferol administration in hemodialysis patients: a simple and efficient strategy for vitamin D supplementation. Nephrol Dial Transplant 2009;24: 3799–3805.
   PubMed Web of Science ®Google Scholar
• Matias PJ, Jorge C, Ferreira C, Borges C, Aires I, Amaral T, . Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimensions parameters. Clin J Am Soc Nephrol 2010;5:905–911.
   PubMed Web of Science ®Google Scholar
• Courbebaisse M, Thervet E, Souberbielle JC, Zuber J, Eladari D, Martinez F, . Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients. Kidney Int 2009;75:646–651.
   PubMed Web of Science ®Google Scholar
• Pilz S, Iodice S, Zittermann A, Grant W, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 2011;58: 374–382.
   PubMed Web of Science ®Google Scholar
• de Boer IH, Katz R, Chonchol M, Sarnak M, Shlipak M, Siskovick D, . Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 2011;6:2141–2149.
   PubMed Web of Science ®Google Scholar
• Kim MJ, Frankel A, Donaldson M, Darch S, Pusey C, Hill P, . Oral cholecalciferol decreases albuminuria and urinary TGF-β1 in patients with type 2 diabetic nephropathy on established renin-angiotensin –aldosterone system inhibition. Kidney Int 2011;80:851–860.
   PubMed Web of Science ®Google Scholar
• Grey A, Lucas J, Horne A, Gamble G, Davidson J, Reid I. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab 2005;90:2122–2126.
   PubMed Web of Science ®Google Scholar
• Souberbielle JC, Maury E, Friedlander G, Cormier C. Vitamin D and primary hyperparathyroidism (PHPT). J Steroid Biochem Mol Biol 2010;121:199–203.
   Google Scholar
• Eastell R, Arnold A, Brandi ML, Brown E, D'Amour P, Hanley D, . Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94: 340–350.
   PubMed Web of Science ®Google Scholar
• Lowe H, McMahon DJ, Rubin M, Bilezikian J, Silverberg S. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 2007;92:3001–3005.
   PubMed Web of Science ®Google Scholar